The Advisory Board Company (NASDAQ:ABCO) has been assigned an average rating of “Hold” from the seventeen ratings firms that are presently covering the company. One research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and six have given a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $47.08.

ABCO has been the subject of several research reports. Stifel Nicolaus lifted their price target on shares of The Advisory Board Company from $38.00 to $47.00 and gave the company a “hold” rating in a report on Tuesday, January 31st. Zacks Investment Research raised shares of The Advisory Board Company from a “strong sell” rating to a “hold” rating in a report on Monday, February 6th. Robert W. Baird reaffirmed a “hold” rating on shares of The Advisory Board Company in a report on Monday, February 6th. Canaccord Genuity lifted their price target on shares of The Advisory Board Company from $36.00 to $56.00 and gave the company a “buy” rating in a report on Thursday, February 9th. Finally, Barclays PLC set a $56.00 price target on shares of The Advisory Board Company and gave the company a “buy” rating in a report on Tuesday, February 14th.

Shares of The Advisory Board Company (NASDAQ:ABCO) traded down 0.69% during midday trading on Tuesday, hitting $50.60. 8,419 shares of the stock were exchanged. The company has a market cap of $2.05 billion, a PE ratio of 20.50 and a beta of 1.15. The Advisory Board Company has a 12-month low of $24.85 and a 12-month high of $54.50. The firm has a 50-day moving average price of $49.13 and a 200-day moving average price of $42.50.

The Advisory Board Company (NASDAQ:ABCO) last posted its quarterly earnings results on Thursday, May 4th. The business services provider reported $0.38 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.12. The Advisory Board Company had a negative net margin of 5.77% and a positive return on equity of 11.28%. The business had revenue of $194.50 million during the quarter, compared to analyst estimates of $188.43 million. During the same period in the previous year, the business posted $0.44 EPS. The company’s quarterly revenue was down 3.1% on a year-over-year basis. On average, equities analysts predict that The Advisory Board Company will post $1.96 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This news story was published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/05/23/the-advisory-board-company-abco-given-average-recommendation-of-hold-by-brokerages.html.

In related news, CEO Robert W. Musslewhite sold 11,000 shares of The Advisory Board Company stock in a transaction dated Monday, April 10th. The shares were sold at an average price of $47.48, for a total value of $522,280.00. Following the sale, the chief executive officer now directly owns 262,587 shares in the company, valued at approximately $12,467,630.76. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Cormac F. Miller sold 750 shares of The Advisory Board Company stock in a transaction dated Wednesday, March 1st. The shares were sold at an average price of $45.16, for a total transaction of $33,870.00. Following the completion of the sale, the insider now owns 18,237 shares in the company, valued at $823,582.92. The disclosure for this sale can be found here. Over the last quarter, insiders sold 83,856 shares of company stock worth $3,867,680. 2.90% of the stock is currently owned by insiders.

Hedge funds have recently added to or reduced their stakes in the company. Howard Hughes Medical Institute bought a new stake in The Advisory Board Company during the first quarter worth approximately $158,000. Russell Investments Group Ltd. bought a new stake in The Advisory Board Company during the fourth quarter worth approximately $3,479,000. Two Sigma Investments LP increased its stake in The Advisory Board Company by 938.7% in the fourth quarter. Two Sigma Investments LP now owns 76,882 shares of the business services provider’s stock worth $2,556,000 after buying an additional 69,480 shares during the period. Federated Investors Inc. PA increased its stake in The Advisory Board Company by 30.7% in the fourth quarter. Federated Investors Inc. PA now owns 50,384 shares of the business services provider’s stock worth $1,675,000 after buying an additional 11,837 shares during the period. Finally, Norges Bank bought a new stake in The Advisory Board Company during the fourth quarter worth approximately $12,464,000.

About The Advisory Board Company

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.

12 Month Chart for NASDAQ:ABCO

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.